Recent Insider Transactions • Jun 04
Independent Director recently sold €63k worth of stock On the 28th of May, John Wilton sold around 18k shares on-market at roughly €3.58 per share. This transaction amounted to 38% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. Insiders have been net sellers, collectively disposing of €40k more than they bought in the last 12 months. Announcement • May 29
Auna S.A., Annual General Meeting, Jun 30, 2026 Auna S.A., Annual General Meeting, Jun 30, 2026, at 15:00 W. Europe Standard Time. Location: 6, rue jean monnet, l-2180 luxembourg, grand duchy of luxembourg, Luxembourg New Risk • May 21
New minor risk - Profit margin trend The company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 1.5% Last year net profit margin: 3.7% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (1.6x net interest cover). Minor Risks Share price has been volatile over the past 3 months (12% average weekly change). Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (1.5% net profit margin). Announcement • Apr 15
Auna S.A. to Report Q1, 2026 Results on May 19, 2026 Auna S.A. announced that they will report Q1, 2026 results After-Market on May 19, 2026 Announcement • Mar 11
Auna S.A. Provides Earnings Guidance for the Fiscal Year 2026 Auna S.A. provided earnings guidance for the fiscal year 2026. For the year, the company expects revenue growth of approximately 12% FXN, within a range of 10% to 14%, driven by continued commercial momentum and operating execution across its core markets. Announcement • Feb 02
Auna S.A. to Report Q4, 2025 Results on Mar 10, 2026 Auna S.A. announced that they will report Q4, 2025 results at 4:00 PM, US Eastern Standard Time on Mar 10, 2026 Announcement • Oct 29
Auna S.A. to Report Q3, 2025 Results on Nov 20, 2025 Auna S.A. announced that they will report Q3, 2025 results After-Market on Nov 20, 2025 Announcement • Jul 15
Auna S.A. to Report Q2, 2025 Results on Aug 19, 2025 Auna S.A. announced that they will report Q2, 2025 results After-Market on Aug 19, 2025 Announcement • Jun 11
UnitedHealth Reportedly Considering Multiple Bids for Latin America Unit UnitedHealth Group Incorporated (NYSE:UNH) is weighing multiple bids for its Latin American operations, according to two people with direct knowledge of the matter, as the insurer buckles down after a series of unprecedented missteps that include the ouster of its CEO and a reported criminal accounting probe. The largest U.S. health insurer has been trying since 2022 to exit Latin America, where it has lost more than $8 billion. But the sale of Banmédica S.A. has taken on increasing urgency in recent months as the insurer took hits on multiple fronts, according to one of the people. Keep up with the latest medical breakthroughs and healthcare trends with the Reuters Health Rounds newsletter. The company has four non-binding bids for its Banmedica subsidiary, which operates in Colombia and Chile, for about $1 billion, according to both people, who asked not to be identified because the talks are private. UnitedHealth's shares tumbled 25.5% in May alone and year-to-date are down 40%. UnitedHealth left Brazil in 2023 and Peru in March. It is aiming to get around $1 billion for Banmedica's operations in Colombia and Chile, the people said. The two people said the company expects to set a deadline for binding proposals as soon as July. UnitedHealth received bids from Washington, D.C.-based private equity firm ACON Investments, L.L.C.; Sao Paulo-based private equity firm Patria Investments Limited (NasdaqGS:PAX), Texas non-profit health firm Christus Health; and Lima-based healthcare and insurance provider Auna S.A. (NYSE:AUNA), the people said. Auna is in talks with a financial partner, one of the sources added. Patria, UnitedHealth Group and Christus Health declined to comment. Acon and Auna did not respond to requests for comment. Announcement • Jun 10
Auna S.A., Annual General Meeting, Jun 30, 2025 Auna S.A., Annual General Meeting, Jun 30, 2025, at 10:00 W. Europe Standard Time. Location: 6 rue jean monnet, l-2180 luxembourg, grand duchy of luxembourg., Luxembourg Announcement • Apr 14
Auna S.A. to Report Q1, 2025 Results on May 20, 2025 Auna S.A. announced that they will report Q1, 2025 results After-Market on May 20, 2025 Announcement • Feb 04
Auna S.A. to Report Q4, 2024 Results on Mar 10, 2025 Auna S.A. announced that they will report Q4, 2024 results After-Market on Mar 10, 2025 Announcement • Dec 19
Auna S.A. Announces Board Changes, effective January 1, 2025 Auna S.A. appointed two new independent directors, Teresa Gutierrez and Guadalupe Phillips, to its Board of Directors, effective January 1, 2025. Ms. Gutierrez is responsible for Tesla in Mexico. Prior to that, she held positions at Rappi, Mattel, Nestle, McKinsey, and Procter and Gamble. She serves on the boards of several public and private companies, including Traxion, DIRI, Vetalia, and Timser. Ms.Phillipsis the Chief Executive Officer of ICA, a prominent construction and infrastructure company in Mexico after a long career holding senior executive positions at Grupo Televisa and its subsidiaries, Mexico’s most prominent media group and largest Spanish-speaking content producer in Latin America. She holds board positions at ICA, Grupo Televisa, Openbank, Volaris, and Grupo Axo. TeresaGutierrez holds a degree in chemical engineering from the Universidad Iberoamericana and an MBA from the IPADE Business School. Guadalupe Phillips holds a law degree from the Instituto Tecnológico Autónomo de México, and earned her master’s and Ph.D. degrees from The Fletcher School of Law and Diplomacy at Tufts University. Announcement • Oct 30
Auna S.A. to Report Q3, 2024 Results on Nov 19, 2024 Auna S.A. announced that they will report Q3, 2024 results After-Market on Nov 19, 2024 Announcement • Sep 03
Auna S.A. Appoints Laurent “Lorenzo” Massart as Executive Vice President, Strategy and Equity Capital Markets to Its Executive Team Auna S.A. announced the appointment of Laurent “Lorenzo” Massart as Executive Vice President, Strategy and Equity Capital Markets to its executive team. In this new role, the Investor Relations function will now report to Lorenzo and thus he will ensure Auna has a cohesive approach to communicating with investors and stakeholders. This appointment is an important signal to the capital markets on the Company´s commitment to position senior talent in key roles and strengthen its relationships with current and future investors. Reported Earnings • Aug 22
Second quarter 2024 earnings released: EPS: S/0.05 (vs S/0.043 in 2Q 2023) Second quarter 2024 results: EPS: S/0.05 (up from S/0.043 in 2Q 2023). Revenue: S/1.12b (up 19% from 2Q 2023). Net income: S/3.75m (up 115% from 2Q 2023). Profit margin: 0.3% (up from 0.2% in 2Q 2023). Revenue is forecast to grow 11% p.a. on average during the next 3 years, compared to a 3.7% growth forecast for the Healthcare industry in Germany. Announcement • Jul 30
Auna S.A. to Report Q2, 2024 Results on Aug 21, 2024 Auna S.A. announced that they will report Q2, 2024 results at 4:00 PM, US Eastern Standard Time on Aug 21, 2024 Announcement • Jul 22
Auna S.A., Annual General Meeting, Aug 06, 2024 Auna S.A., Annual General Meeting, Aug 06, 2024, at 10:30 W. Europe Standard Time. Location: sofitel kirchberg, 6, rue du fort niedergruenewald, l-2226 luxembourg, grand duchy of luxembourg., Luxembourg Announcement • Jul 18
Auna S.A. Launches the First Integrated Oncology Insurance in Mexico Auna S.A. announced the launch of the first oncology insurance in Mexico, fully integrated through its hospital network in Monterrey, Nuevo Leon. Auna's integrated oncological insurance addresses the unmet needs of families and patients for cancer prevention, detection, and treatment coverage. The product, named after its successful predecessors in Peru, “OncoSalud”, covers the latest medical guidelines and protocols, as well as technology, within its Monterrey hospital network. OncoSalud benefits from over 35 years of product experience in Peru alongside outstanding oncology research capabilities in Colombia that have resulted in first-world survivor rates for its cancer patients. The insurance product is tailored for families with members aged 70 years and younger without pre-existing oncological conditions. OncoSalud has been attractively priced at USD 40 per month on average, and policyholders benefit from an annual insured amount of up to USD 0.5 million. OncoSalud is well regarded for its focus on prevention and early detection, thus preventive check-ups and related diagnostic exams are free to policyholders. Reported Earnings • May 23
First quarter 2024 earnings released: S/0.28 loss per share (vs S/0.11 loss in 1Q 2023) First quarter 2024 results: S/0.28 loss per share (further deteriorated from S/0.11 loss in 1Q 2023). Revenue: S/1.08b (up 20% from 1Q 2023). Net loss: S/13.3m (loss widened 249% from 1Q 2023). Revenue is forecast to grow 11% p.a. on average during the next 3 years, compared to a 3.8% growth forecast for the Healthcare industry in Germany. Announcement • May 10
Auna S.A. to Report Q1, 2024 Results on May 22, 2024 Auna S.A. announced that they will report Q1, 2024 results After-Market on May 22, 2024 Board Change • Apr 03
Insufficient new directors There is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 4 experienced directors. 3 highly experienced directors. Independent Director Anasofía Sánchez Cardoze was the last director to join the board, commencing their role in 2023. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. 